{"ORPHApacket":[{"ORPHApacketID":"438216","date":"2019-12-06 05:02:11","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"438216","Name":[{"lang":"en","label":"PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_438216","DisorderType":[{"Name":[{"lang":"en","label":"Etiological subtype"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377795"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome"}],"ORPHA":"438213","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_438213"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation is a rare, genetic neurological disease, with a highly variable phenotype, typically characterized by neonatal hypotonia, respiratory and feeding difficulties, global development delay (often with nonverbal and frequently non-ambulatory progression) and myopathic facies. Other frequently present features include seizures (or seizure-like episodes), visual impairment and encephalopathy."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"616158","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"2","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Infancy"}]},{"Name":[{"lang":"en","label":"Neonatal"}]}]}],"TypeOfInheritanceList":[{"count":"2","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal dominant"}]},{"Name":[{"lang":"en","label":"Not applicable"}]}]}]}]}